Morgan Stanley’s InfuSystem Holdings INFU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $816K | Buy |
88,408
+21,921
| +33% | +$191K | ﹤0.01% | 5248 |
|
|
2025
Q4 | $596K | Buy |
66,487
+22,236
| +50% | +$213K | ﹤0.01% | 5418 |
|
|
2025
Q3 | $458K | Sell |
44,251
-30,052
| -40% | -$249K | ﹤0.01% | 5534 |
|
|
2025
Q2 | $464K | Sell |
74,303
-16,576
| -18% | -$91.6K | ﹤0.01% | 5494 |
|
|
2025
Q1 | $489K | Sell |
90,879
-7,970
| -8% | -$58.3K | ﹤0.01% | 5333 |
|
|
2024
Q4 | $835K | Sell |
98,849
-2,059
| -2% | -$16.2K | ﹤0.01% | 5171 |
|
|
2024
Q3 | $676K | Buy |
100,908
+32,316
| +47% | +$209K | ﹤0.01% | 5255 |
|
|
2024
Q2 | $468K | Buy |
68,592
+38,888
| +131% | +$286K | ﹤0.01% | 5321 |
|
|
2024
Q1 | $255K | Sell |
29,704
-49,612
| -63% | -$466K | ﹤0.01% | 5638 |
|
|
2023
Q4 | $836K | Buy |
79,316
+66,397
| +514% | +$652K | ﹤0.01% | 5386 |
|
|
2023
Q3 | $125K | Sell |
12,919
-4,900
| -27% | -$50.1K | ﹤0.01% | 5781 |
|
|
2023
Q2 | $172K | Sell |
17,819
-6,350
| -26% | -$57.5K | ﹤0.01% | 5708 |
|
|
2023
Q1 | $187K | Buy |
24,169
+12,967
| +116% | +$119K | ﹤0.01% | 5731 |
|
|
2022
Q4 | $97.2K | Buy |
11,202
+8,657
| +340% | +$70.5K | ﹤0.01% | 5987 |
|
|
2022
Q3 | $18K | Sell |
2,545
-20,698
| -89% | -$173K | ﹤0.01% | 6834 |
|
|
2022
Q2 | $224K | Buy |
23,243
+16,237
| +232% | +$142K | ﹤0.01% | 5840 |
|
|
2022
Q1 | $69K | Sell |
7,006
-6,188
| -47% | -$79.5K | ﹤0.01% | 6534 |
|
|
2021
Q4 | $224K | Sell |
13,194
-100,394
| -88% | -$1.59M | ﹤0.01% | 6004 |
|
|
2021
Q3 | $1.48M | Buy |
113,588
+4,494
| +4% | +$73.3K | ﹤0.01% | 4796 |
|
|
2021
Q2 | $2.27M | Buy |
109,094
+67,950
| +165% | +$1.37M | ﹤0.01% | 4531 |
|
|
2021
Q1 | $837K | Buy |
41,144
+20,525
| +100% | +$384K | ﹤0.01% | 4833 |
|
|
2020
Q4 | $387K | Buy |
20,619
+9,315
| +82% | +$140K | ﹤0.01% | 5234 |
|
|
2020
Q3 | $144K | Buy |
11,304
+4,583
| +68% | +$59.5K | ﹤0.01% | 5264 |
|
|
2020
Q2 | $78K | Buy |
6,721
+5,212
| +345% | +$59.9K | ﹤0.01% | 5512 |
|
|
2020
Q1 | $13K | Sell |
1,509
-492
| -25% | -$4.44K | ﹤0.01% | 5954 |
|
|
2019
Q4 | $17K | Sell |
2,001
-260
| -11% | -$1.91K | ﹤0.01% | 6138 |
|
|
2019
Q3 | $12K | Buy |
2,261
+381
| +20% | +$1.84K | ﹤0.01% | 6149 |
|
|
2019
Q2 | $8K | Buy |
1,880
+1,827
| +3,447% | +$8.48K | ﹤0.01% | 6189 |
|
|
2019
Q1 | $0 | Sell |
53
-214
| -80% | -$852 | ﹤0.01% | 6635 |
|
|
2018
Q4 | $1K | Sell |
267
-4,242
| -94% | -$14K | ﹤0.01% | 6503 |
|
|
2018
Q3 | $15K | Buy |
4,509
+315
| +8% | +$1.03K | ﹤0.01% | 6212 |
|
|
2018
Q2 | $15K | Buy |
+4,194
| New | +$12.4K | ﹤0.01% | 6217 |
|
|
2017
Q3 | – | Sell |
-6
| Closed | – | – | 6561 |
|
|
2017
Q2 | $0 | Buy |
+6
| New | +$11 | ﹤0.01% | 6614 |
|
|
2016
Q3 | – | Sell |
-400
| Closed | -$1K | – | 6529 |
|
|
2016
Q2 | $1K | Hold |
400
| – | – | ﹤0.01% | 6424 |
|
|
2016
Q1 | $1K | Buy |
+400
| New | +$1.26K | ﹤0.01% | 6468 |
|
|
2015
Q2 | – | Sell |
-43
| Closed | – | – | 6690 |
|
|
2015
Q1 | $0 | Sell |
43
-5,250
| -99% | -$14.2K | ﹤0.01% | 6594 |
|
|
2014
Q4 | $17K | Buy |
5,293
+651
| +14% | +$2.07K | ﹤0.01% | 6092 |
|
|
2014
Q3 | $14K | Buy |
4,642
+3,907
| +532% | +$11K | ﹤0.01% | 6107 |
|
|
2014
Q2 | $2K | Buy |
+735
| New | +$2.02K | ﹤0.01% | 6387 |
|
Other funds holding INFU
MA
VCM
PAIM
HA
Morgan Stanley's INFU Position: Q1 2026 in Review
Morgan Stanley increased its InfuSystem Holdings (INFU) stake by 33% in Q1 2026, buying an estimated $191K and bringing the position to 88,408 shares worth $816K. The position accounts for ﹤0.01% of the portfolio, ranked #5248.
Morgan Stanley first reported a position in INFU in Q2 2014 and has held it in 39 quarters since. The position peaked at $2.27M in Q2 2021. 96 funds tracked by Wall St. Rank hold INFU as of Q1 2026.
- Morgan Stanley held 88,408 shares of InfuSystem Holdings worth $816K as of Q1 2026.
- Morgan Stanley bought 21,921 InfuSystem Holdings shares in Q1 2026, an estimated $191K.
- InfuSystem Holdings made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #5248 holding.
- Morgan Stanley first reported a position in InfuSystem Holdings in Q2 2014 and has held it in 39 quarters since.
- Morgan Stanley's InfuSystem Holdings position peaked at $2.27M in Q2 2021.
- 96 funds tracked by Wall St. Rank held InfuSystem Holdings as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.